SCHEMBL20037562

SCHEMBL20037562

Cc1ccc(N2CCNCC2)c(F)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 4/20 0.48
NCF1 P14598 3/20 0.48
ADRB2 P07550 2/20 0.48
HTR7 P34969 2/20 0.46
HTR3E A5X5Y0 2/20 0.44
HTR3B O95264 2/20 0.44
HTR3A P46098 2/20 0.44
HTR3D Q70Z44 2/20 0.44
HTR3C Q8WXA8 2/20 0.44
OPRL1 P41146 1/20 0.43
HTR6 P50406 3/20 0.42
ADRA2A P08913 1/20 0.42
HTR2C P28335 1/20 0.42
AXL P30530 1/20 0.42
HRH1 P35367 1/20 0.42
HTR2B P41595 1/20 0.42
MKNK1 Q9BUB5 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
CYP1A2 P05177 1/20 0.41
HTR1A P08908 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30297103 1.00 ADRB1 (0.48) ADRB1NCF1ADRB2HTR7HTR3E
SCHEMBL2366124 0.82 ADRB1 (0.50) ADRB1NCF1ADRB2HTR7HTR3E
SCHEMBL30484798 0.79 NCF1 (0.48) ADRB1NCF1HTR7HTR3EHTR3B
SCHEMBL18291599 0.79 NCF1 (0.48) ADRB1NCF1HTR7HTR3EHTR3B
SCHEMBL20255446 0.79 HTR7 (0.44) ADRB1NCF1HTR7HTR3EHTR3B
SCHEMBL20249187 0.79 HTR6 (0.45) ADRB1NCF1ADRB2HTR7HTR3E
Hydrochloric Acid SCHEMBL30888868 0.79 ALDH1A1 (0.45) HTR2C
SCHEMBL2881030 0.79 HTR1A (0.46) ADRB1NCF1ADRB2HTR7HTR3E
SCHEMBL24632960 0.76 CDK4 (0.41) HRH1CYP2D6TSHRHSD17B10
SCHEMBL24197880 0.75 HTR3E (0.41) ADRB1HTR7HTR3EHTR3BHTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305785-A1 PYRIDO[3,4-d]PYRIMIDINE DERIVATIVE AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Teijin Pharma Limited (JP) 2018-04-11 EP disclosed